• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More or Call (407) 374-6986

Monday 12/17/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

SilverSun Technologies

  • SilverSun Technologies
    11:23 AM

    LIVINGSTON, N.J., Jan. 30, 2017, SSNT, (GLOBE NEWSWIRE) — SilverSun Technologies, Inc. (OTCBB:SSNT) (OTCQB:SSNT), a national provider of transformational business technology solutions and services, today announced that it has submitted its formal application to list the Company’s common stock on the NASDAQ Capital Market. Mark Meller, Chairman and CEO of  SilverSun, stated, “The listing of our Company’s securities on NASDAQ, along with maintaining the profitable 29% compound annual growth rate we have delivered over the past 7 years, was our

    Read more
  • SilverSun Technologies
    3:39 PM

    LIVINGSTON, N.J., Jan. 11, 2016, SSNT, (GLOBE NEWSWIRE) — SilverSun Technologies, Inc. (OTCBB:SSNT), a national provider of transformational business technology solutions and services, today announced that its Board of Directors has declared a special cash dividend on the Company’s common stock of $0.06 per share. The record date will be January 15, 2016, and the payment date will be January 20, 2016. “We believe this special one-time cash dividend–the first in our Company’s history–is an appropriate way to reward our

    Read more
  • 4:54 PM

    http://www.publicwire.com EL PASO, Texas, Apr 02, 2014 (BUSINESS WIRE) — Premier Biomedical, Inc. (OTCBB:BIEI), a biopharmaceutical company focused on developing and commercializing innovative immune-system manipulation therapies, has prepared and will file a provisional patent application for an anti-breast cancer treatment methodology protocol, in conjunction with its partners in R&D at the Department of Defense (DOD) with Center of Expertise at the William Beaumont Army Medical Center and the University of Texas at El Paso (UTEP) covering its study accepted for

    Read more
Public Wire Banner